Rafa Laboratories Ltd. (TLV:RAFA)

Revenue by Segment

Financials in millions ILS. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023
Pharmaceuticals	262.81M	265.92M	275.01M
Biodefense	155.63M	154.16M	80.19M
Total	418.44M	420.08M	355.20M

Revenue by Geography

Financials in millions ILS. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024
Period Ending	Dec 31, 2025	Dec 31, 2024
Israel	253.26M	261.97M
USA	70.41M	96.69M
The Rest of The World	36.82M	46.55M
Germany	57.96M	14.87M
Total	418.44M	420.08M

Data Source: S&P Global Market Intelligence Last updated: Jul 9, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 30, 2026

Data Sources Report a data error